Nova Scotia Health Authority. Northern Zone. Primary Care. Halifax, NS: Nova Scotia Health Authority , 2023.

Pamphlet Number

2337

Available Online

View Pamphlet

This pamphlet gives information on what to expect before you book an appointment at your collaborative family practice. Information on what to do when you are not able to book an appointment is also listed.

Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.

Pamphlet Number

1140

Available Online

View Pamphlet

Your health care provider feels that treatment with infliximab may help you to manage your inflammatory bowel disease (IBD). This pamphlet describes what infliximab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.

Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.

Pamphlet Number

1207

Available Online

View Pamphlet

Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.

Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.

Pamphlet Number

1641

Available Online

View Pamphlet

Your health care provider feels that treatment with golimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what golimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.

Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.

Pamphlet Number

1623

Available Online

View Pamphlet

Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when und…

Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.

Pamphlet Number

1483

Available Online

View Pamphlet

5-aminosalicylate (5-ASA) is a medication often used to treat inflammatory bowel disease (IBD). It helps to controll active ulcerative colitis, or Crohn’s colitis and keep mild to moderate ulcerative colitis in remission (period of recovery). Topics include: what does 5-ASA do, which 5-ASA you should take, how to take 5-ASA, what other medications you can take, and how 5-ASA will help. The pamphlet also describes side effects and how long you will need to take 5-ASA.

Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.

Pamphlet Number

1695

Available Online

View Pamphlet

Your IBD health care provider believes treatment with a medication called ustekinumab may help to manage your inflammatory bowel disease (IBD). The brand name for ustekinumab is Stelara®. This pamphlet will give you basic information about ustekinumab to help you make an informed decision about whether or not to use this treatment. Topics include what ustekinumab is, how it works, how it is given, how long you will need to take it, and how much it will cost. Considerations before you start taki…

Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.

Pamphlet Number

1138

Available Online

View Pamphlet

Methotrexate (MTX) may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about what MTX is, combination therapy in IBD, who should not take MTX, how MTX is given, and possible side effects, and what you can do to lower the chance of side effects.

Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.

Pamphlet Number

1546

Available Online

View Pamphlet

A corticosteroid medication may help you manage your inflammatory bowel disease (IBD). This pamphlet explains what corticosteroids are, how well they work, and how they are given. Information about precautions, possible side effects, and what to expect after your treatment is included.

Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.

Pamphlet Number

1079

Available Online

View Pamphlet

Azathioprine (Imuran®) or mercaptopurine may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about combination therapy in IBD, possible side effects of these medications, and what you can do to lower the chance of side effects.

Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2023.

Pamphlet Number

2345

Available Online

View Pamphlet

Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.